Clinical Trial Update: Evaluation of Efficacy and Safety of Nilotinib in Combination With Chemotherapy in Elderly Patients With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of nilotinib in combination with chemotherapy for elderly patients with Philadelphia chromosome positive acute …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

Sponsor: Goethe University | Conditions: Philadelphia Chromsome Positive Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED